Cargando…
COVID-19 therapeutic options for patients with kidney disease
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271263/ https://www.ncbi.nlm.nih.gov/pubmed/32317113 http://dx.doi.org/10.1016/j.kint.2020.03.015 |
_version_ | 1783542059374739456 |
---|---|
author | Izzedine, Hassan Jhaveri, Kenar D. Perazella, Mark A. |
author_facet | Izzedine, Hassan Jhaveri, Kenar D. Perazella, Mark A. |
author_sort | Izzedine, Hassan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7271263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Society of Nephrology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72712632020-06-05 COVID-19 therapeutic options for patients with kidney disease Izzedine, Hassan Jhaveri, Kenar D. Perazella, Mark A. Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2020-06 2020-03-30 /pmc/articles/PMC7271263/ /pubmed/32317113 http://dx.doi.org/10.1016/j.kint.2020.03.015 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Izzedine, Hassan Jhaveri, Kenar D. Perazella, Mark A. COVID-19 therapeutic options for patients with kidney disease |
title | COVID-19 therapeutic options for patients with kidney disease |
title_full | COVID-19 therapeutic options for patients with kidney disease |
title_fullStr | COVID-19 therapeutic options for patients with kidney disease |
title_full_unstemmed | COVID-19 therapeutic options for patients with kidney disease |
title_short | COVID-19 therapeutic options for patients with kidney disease |
title_sort | covid-19 therapeutic options for patients with kidney disease |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271263/ https://www.ncbi.nlm.nih.gov/pubmed/32317113 http://dx.doi.org/10.1016/j.kint.2020.03.015 |
work_keys_str_mv | AT izzedinehassan covid19therapeuticoptionsforpatientswithkidneydisease AT jhaverikenard covid19therapeuticoptionsforpatientswithkidneydisease AT perazellamarka covid19therapeuticoptionsforpatientswithkidneydisease |